Fluoxymesterone

Product Name: Fluoxymesterone

Synonym: Fluoxymesterone;Halotestin;

CAS No.: 76-43-7

MF: C20H29FO3

MW: 336.44

EINECS: 200-961-8

Assay: 99% min

Melting point: 240 °C

Alpha: 104 º (c=1,EtOH)

Storage temp.: 20°C

Storage: Shading, confined preservation.

Solubility: H2O: ≤0.5 mg/mL (Negligible)

Chemical Properties: White to light yellow crystal powder (photosensitive)

Grade: Pharmaceutical Grade

Effective Dose: 10-40mgs/day

Active life: 6-8 hours

Product Categories: Organics;chiral;Steroids;Steroid and Hormone;Intermediates & Fine Chemicals;Pharmaceuticals;API;teroids;Inhibitors.

Usage: used for strength gains, steroid bulking cycle, used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women.
 

Fluoxymesterone (trade name Halotestin) is an anabolic steroid with strong androgenic properties that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. It is approximately 5 times as potent as methyltestosterone. The antitumor activity of fluoxymesterone appears related to reduction or competitive inhibition of prolactin receptors or estrogen receptors or production.

Halotestin contains fluoxymesterone, which is known to help the body produce more androgenic hormone. Fluoxymesterone is colorless, odorless, and insoluble in water. The drug is said to be 19 times more anabolic and eight times more androgenic compared to other anabolic steroids in the market. This means that the drug can instantly turn you into a scrawny person to a body builder within an instant. 
 

Halotestin is most usually prescribed for men. They should be taken not just for sports-related applications, but also when:

Men suffer from absence or deficiency of endogenous testosterone, leading to conditions like vanishing testes syndrome, cryptochoridism, and orchitis. The deficiency of the endogenous testosterone can also be caused by traumatic syndromes and severe accidents.

Men suffer from delayed puberty.

In rare cases, Halotestin is given to women who suffer from mammary cancer and are post-menopausal.